From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Diabetes>
  4. Archives

Diabetes: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 176-200 of 526 are shown

Group Visits for Diabetes Patients

Group visits led to better blood pressure control but not better glycemic control.

Differences in Glycosylated Hemoglobin — Independent of Glucose Levels — Between Blacks and Whites

Using a single HbA1c level as an indicator of diabetes might not be as straightforward as it seems.

  • By Jamaluddin Moloo, MD, MPH
  • June 24, 2010
  • Covering:
    • Ziemer DC et al., Ann Intern Med 2010 Jun 15; 152:770
    • Herman WH and Cohen RM., Ann Intern Med 2010 Jun 15; 152:815

Metabolic Syndrome and Risk for Myocardial Infarction

Risk conferred by metabolic syndrome was similar to that conferred by diabetes alone.

Long-Term Metformin Raises Risk for B12 Deficiency

Routine B12 monitoring is recommended.

Hamburgers, Hot Dogs, and Heart Health

In a meta-analysis of observational data, consumption of processed meat conferred higher risks for coronary heart disease and diabetes than consumption of unprocessed red meat.

Staying Ahead of the Curve

Researchers relate trends in cardiovascular prevention and treatment to recent improvements in mortality from coronary heart disease.

Glycemic Control and Mortality in Hemodialysis Patients

Management of dialysis patients should not be focused on tight glycemic control.

  • By Allan S. Brett, MD
  • May 27, 2010
  • Covering:
    • Shurraw S et al., Am J Kidney Dis 2010 May; 55:875

Depression Worsens Outcome in Chronic Kidney Disease

The association is broadened to predialysis patients.

Treatment-Induced Diabetic Neuropathy

An unusual complication of rapid intensive glycemic control

  • By Allan S. Brett, MD
  • May 20, 2010
  • Covering:
    • Gibbons CH and Freeman R., Ann Neurol 2010 Apr; 67:534

Liraglutide vs. Sitagliptin for Type 2 Diabetes: Liraglutide Wins an Early Round

Mean decreases in glycosylated hemoglobin and fasting glucose levels were significantly greater with liraglutide.

  • By Bruce Soloway, MD
  • May 18, 2010
  • Covering:
    • Pratley RE et al., Lancet 2010 Apr 24; 375:1447

Addicted to Food

A study in rats reveals dysfunction in the reward system with unlimited access to rich foods, similar to cocaine addictions.

  • By Steven Dubovsky, MD
  • May 17, 2010
  • Covering:
    • Johnson PM and Kenny PJ., Nat Neurosci 2010 May; 13:635

Diabetic Nephropathy Worsens with B-Vitamin Supplementation

Plasma homocysteine levels declined, but so did glomerular filtration rates.

Pancreatic {alpha} Cells Can Become β Cells Naturally

In mice, in vivo depletion of β cells caused {alpha} cells to become β cells.

A Mathematical Model Supports Age-Based Screening for Diabetes

A cost-effectiveness analysis supports starting screening between the ages of 30 and 45.

  • By Bruce Soloway, MD
  • April 27, 2010
  • Covering:
    • Kahn R et al., Lancet 2010 Apr 17; 375:1365

Industry Affiliation and Position on the Rosiglitazone Controversy

Authors with industry links were more likely to have positive views about rosiglitazone's risk profile.

Women from JUPITER . . .

. . . benefited from rosuvastatin as much as men did.

  • By JoAnne M. Foody, MD
  • April 14, 2010
  • Covering:
    • Mora S et al., Circulation 2010 Mar 9; 121:1069

Salsalate Treatment Lowers Glycosylated Hemoglobin Levels

Long-term safety data are needed before salsalate can be used routinely in patients with type 2 diabetes.

Frequency of Visits Before New Diagnosis of Diabetes in Children

In a Canadian study, most children saw a doctor at least once during the 4 weeks before a new diagnosis of diabetes.

The ACCORD Lipid Study: Fenofibrate Doesn't Help

Although triglyceride levels improved markedly with fenofibrate, incidence of adverse cardiovascular events was not affected.

The ACCORD Blood Pressure Study: What Target for High-Risk Diabetic Patients?

Achieving systolic blood pressure levels lower than 140 mm Hg does not prevent adverse cardiovascular events.

Diabetes and Cardiovascular Events: Not a Straight Course

A study of two drugs for the primary prevention of diabetes yielded disappointing results.

  • By Harlan M. Krumholz, MD, SM
  • March 14, 2010
  • Covering:
    • The NAVIGATOR Study Group., N Engl J Med 2010 Mar 14
    • The NAVIGATOR Study Group., N Engl J Med 2010 Mar 14
    • Nathan DM., N Engl J Med 2010 Mar 14

More on Depression and Diabetes

Even low-grade preexisting depression may increase the risk for diabetes.

  • By Joel Yager, MD
  • March 8, 2010
  • Covering:
    • Campayo A et al., Am J Psychiatry 2010 Feb 1

Cardiovascular Benefits of Statins vs. Risk for Incident Diabetes

One additional case of incident diabetes occurred for every 255 patients who received statins for 4 years.

  • By Bruce Soloway, MD
  • March 4, 2010
  • Covering:
    • Sattar N et al., Lancet 2010 Feb 27; 375:735

Glycosylated Hemoglobin and Cardiovascular Risk in Nondiabetic Adults

Even within the normal range, HbA1c level correlated with diabetes risk.

  • By Allan S. Brett, MD
  • March 4, 2010
  • Covering:
    • Selvin E et al., N Engl J Med 2010 Mar 4; 362:800

Sharing Cardiovascular Risk Information with Patients

Patients benefit from getting their risk scores, but only if it's done repeatedly or reinforced with counseling.

  • By Frederick A. Masoudi, MD, MSPH
  • March 3, 2010
  • Covering:
    • Sheridan SL et al., Arch Intern Med 2010 Feb 8; 170:230
    • Ahmad T and Mora S., Arch Intern Med 2010 Feb 8; 170:227
Items 176-200 of 526 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.